rs781947413

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_000117.3(EMD):​c.746A>G​(p.Glu249Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,206,525 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 17 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000037 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000039 ( 0 hom. 15 hem. )

Consequence

EMD
NM_000117.3 missense

Scores

1
4
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.824

Publications

2 publications found
Variant links:
Genes affected
EMD (HGNC:3331): (emerin) Emerin is a serine-rich nuclear membrane protein and a member of the nuclear lamina-associated protein family. It mediates membrane anchorage to the cytoskeleton. Dreifuss-Emery muscular dystrophy is an X-linked inherited degenerative myopathy resulting from mutation in the emerin gene. [provided by RefSeq, Jul 2008]
EMD Gene-Disease associations (from GenCC):
  • X-linked Emery-Dreifuss muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • heart conduction disease
    Inheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14998612).
BP6
Variant X-154381178-A-G is Benign according to our data. Variant chrX-154381178-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 531737.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.0000392 (43/1097088) while in subpopulation NFE AF = 0.0000511 (43/841466). AF 95% confidence interval is 0.0000385. There are 0 homozygotes in GnomAdExome4. There are 15 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EMDNM_000117.3 linkc.746A>G p.Glu249Gly missense_variant Exon 6 of 6 ENST00000369842.9 NP_000108.1 P50402

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EMDENST00000369842.9 linkc.746A>G p.Glu249Gly missense_variant Exon 6 of 6 1 NM_000117.3 ENSP00000358857.4 P50402

Frequencies

GnomAD3 genomes
AF:
0.0000366
AC:
4
AN:
109437
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000764
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000494
AC:
9
AN:
182047
AF XY:
0.0000593
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000111
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000392
AC:
43
AN:
1097088
Hom.:
0
Cov.:
32
AF XY:
0.0000414
AC XY:
15
AN XY:
362600
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26381
American (AMR)
AF:
0.00
AC:
0
AN:
35175
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19349
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30155
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54121
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40285
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4126
European-Non Finnish (NFE)
AF:
0.0000511
AC:
43
AN:
841466
Other (OTH)
AF:
0.00
AC:
0
AN:
46030
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000366
AC:
4
AN:
109437
Hom.:
0
Cov.:
23
AF XY:
0.0000629
AC XY:
2
AN XY:
31787
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29940
American (AMR)
AF:
0.00
AC:
0
AN:
10363
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2615
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3466
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2484
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5868
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.0000764
AC:
4
AN:
52330
Other (OTH)
AF:
0.00
AC:
0
AN:
1456
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.0000264
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Emery-Dreifuss muscular dystrophy 1, X-linked Uncertain:1
Jul 30, 2021
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not provided Benign:1
May 16, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

X-linked Emery-Dreifuss muscular dystrophy Benign:1
Sep 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Apr 26, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.51
D;T
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.61
T;T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.15
T;T
MetaSVM
Benign
-0.41
T
MutationAssessor
Benign
1.9
L;.
PhyloP100
0.82
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.5
N;N
REVEL
Benign
0.10
Sift
Uncertain
0.029
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.0090
B;.
Vest4
0.15
MutPred
0.23
Loss of stability (P = 0.139);.;
MVP
0.67
MPC
0.71
ClinPred
0.17
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.2
Varity_R
0.11
gMVP
0.21
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781947413; hg19: chrX-153609538; API